Henry Schein, Inc. (NASDAQ:HSIC) Shares Purchased by HighTower Advisors LLC

HighTower Advisors LLC boosted its stake in shares of Henry Schein, Inc. (NASDAQ:HSIC - Free Report) by 242.9% during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 43,347 shares of the company's stock after purchasing an additional 30,706 shares during the period. HighTower Advisors LLC's holdings in Henry Schein were worth $3,000,000 at the end of the most recent reporting period.

A number of other hedge funds have also bought and sold shares of HSIC. Versant Capital Management Inc grew its holdings in shares of Henry Schein by 274.6% during the fourth quarter. Versant Capital Management Inc now owns 457 shares of the company's stock valued at $32,000 after buying an additional 335 shares during the last quarter. Venturi Wealth Management LLC grew its stake in Henry Schein by 3,347.1% during the 4th quarter. Venturi Wealth Management LLC now owns 586 shares of the company's stock valued at $41,000 after purchasing an additional 569 shares during the last quarter. Quent Capital LLC increased its holdings in shares of Henry Schein by 91.2% in the fourth quarter. Quent Capital LLC now owns 677 shares of the company's stock valued at $47,000 after purchasing an additional 323 shares during the period. Smartleaf Asset Management LLC raised its stake in shares of Henry Schein by 23.2% in the fourth quarter. Smartleaf Asset Management LLC now owns 759 shares of the company's stock worth $52,000 after purchasing an additional 143 shares during the last quarter. Finally, City State Bank acquired a new stake in shares of Henry Schein during the fourth quarter worth about $55,000. Institutional investors and hedge funds own 96.62% of the company's stock.

Remove Ads

Wall Street Analyst Weigh In

A number of equities analysts have issued reports on HSIC shares. Bank of America raised shares of Henry Schein from an "underperform" rating to a "buy" rating and raised their price target for the stock from $69.00 to $84.00 in a research report on Monday, January 6th. Barrington Research reissued an "outperform" rating and set a $90.00 target price on shares of Henry Schein in a report on Wednesday, February 26th. Wells Fargo & Company initiated coverage on shares of Henry Schein in a research report on Friday, February 14th. They set an "equal weight" rating and a $80.00 target price for the company. Mizuho initiated coverage on Henry Schein in a research report on Wednesday, December 4th. They set a "neutral" rating and a $75.00 price target on the stock. Finally, Jefferies Financial Group boosted their price objective on Henry Schein from $77.00 to $80.00 and gave the company a "hold" rating in a report on Thursday, January 23rd. Six research analysts have rated the stock with a hold rating, five have assigned a buy rating and one has given a strong buy rating to the company. According to data from MarketBeat.com, Henry Schein has a consensus rating of "Moderate Buy" and a consensus target price of $81.10.

Insider Transactions at Henry Schein

In other news, Director Philip A. Laskawy sold 2,604 shares of the company's stock in a transaction that occurred on Wednesday, March 19th. The shares were sold at an average price of $71.04, for a total value of $184,988.16. Following the transaction, the director now directly owns 24,805 shares in the company, valued at approximately $1,762,147.20. This represents a 9.50 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. Also, CEO Bradford C. Connett sold 4,036 shares of Henry Schein stock in a transaction on Wednesday, March 19th. The shares were sold at an average price of $71.15, for a total value of $287,161.40. Following the completion of the sale, the chief executive officer now directly owns 62,688 shares of the company's stock, valued at $4,460,251.20. The trade was a 6.05 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders own 1.14% of the company's stock.

Henry Schein Price Performance

Shares of HSIC traded down $1.38 during trading hours on Tuesday, hitting $69.38. 1,295,927 shares of the stock were exchanged, compared to its average volume of 1,508,724. The stock's 50-day moving average price is $74.82 and its two-hundred day moving average price is $72.64. The company has a debt-to-equity ratio of 0.46, a quick ratio of 0.82 and a current ratio of 1.42. The company has a market cap of $8.62 billion, a price-to-earnings ratio of 28.55, a price-to-earnings-growth ratio of 2.13 and a beta of 0.90. Henry Schein, Inc. has a 12-month low of $63.67 and a 12-month high of $82.49.

Henry Schein (NASDAQ:HSIC - Get Free Report) last issued its earnings results on Tuesday, February 25th. The company reported $1.19 EPS for the quarter, missing analysts' consensus estimates of $1.23 by ($0.04). Henry Schein had a net margin of 2.51% and a return on equity of 12.90%. The business had revenue of $3.19 billion during the quarter, compared to analyst estimates of $3.25 billion. Henry Schein's quarterly revenue was up 5.8% on a year-over-year basis. During the same quarter last year, the company earned $0.66 earnings per share. Research analysts expect that Henry Schein, Inc. will post 4.74 earnings per share for the current year.

Henry Schein Company Profile

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.